Rufinamide for Epilepsy Research: Utilizing rufinamide in therapeutic drug monitoring, a study enhanced the understanding of drug levels in epilepsy treatment using mass spectrometry, aligning with practices in neurology research and pharmaceutical quality control (Kim et al., 2024).
Pharmacokinetics of Rufinamide: A network meta-analysis of randomized, placebo-controlled trials evaluated the efficacy, tolerability, and safety of third-generation antiseizure medications, including rufinamide, underscoring its role in global epilepsy treatment strategies (Chen et al., 2024).
Rufinamide in Neuropharmacology: Research on the inhibition of resurgent Na(+) currents by rufinamide contributes to the understanding of its mechanism in neurological pathways, aiding in the development of targeted epilepsy treatments (Chen and Kuo, 2024).
法律資訊
CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany
Snap-N-Shoot is a registered trademark of Cerilliant Corporation
Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany